CoChat

Effects of steroidal mineralocorticoid receptor antagonists on acute and chronic estimated glomerular filtration rate slopes in patients with chronic heart failure

Open access
Vaduganathan, Muthiah, Ferreira, João Pedro, Rossignol, Patrick, Neuen, Brendon L., Claggett, Brian L., Pfeffer, Marc A., McMurray, John J.V., Pitt, Bertram, Zannad, Faiez, Solomon, Scott D. · 2022 · European Journal of Heart Failure
Cited by 43

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Abstract

Aims: Steroidal mineralocorticoid receptor antagonists (MRAs) form a cornerstone of the management of heart failure (HF), but little is known about the long‐term effects of MRA therapy on kidney function. We evaluated acute and chronic estimated glomerular function (eGFR) slopes in the two largest completed trials testing steroidal MRAs in chronic HF. Methods and results: We conducted parallel post hoc eGFR slope analyses in two multinational, double‐blind randomized, placebo‐controlled trials of steroidal MRAs in chronic HF with reduced ejection fraction (EMPHASIS‐HF) and preserved ejection fraction (TOPCAT Americas region). GFR was estimated using the Chronic Kidney Disease Epidemiology Collaboration equation. Annual slopes of eGFR were assessed by generalized random coefficient models. Least square mean differences in eGFR slopes between steroidal MRA and placebo arms were assessed. Median follow‐up was 1.8 years (EMPHASIS‐HF) and 3.3 years (TOPCAT Americas). From baseline to month 4–6 (‘acute eGFR slope’), compared to placebo, MRA treatment led to an acute decline in eGFR of −2.4 ml/min/1.73 m 2 (95% confidence interval [CI] −3.4 to −1.4; p < 0.001) and −2.0 ml/min/1.73 m 2 (95% CI −3.0 to −1.8; p < 0.001) in EMPHASIS‐HF and TOPCAT Americas, respectively. From month 4–6 to end of study, there was no difference in ‘chronic eGFR slope’ between MRA and placebo arms (−0.3 ml/min/1.73 m 2 /year [95% CI −1.3 to 0.7; p = 0.53] and 0.1 ml/min/1.73 m 2 /year [95% CI −1.4 to 1.7; p = 0.86]) in EMPHASIS‐HF and TOPCAT Americas, respectively. Conclusions: Steroidal MRAs result in acute declines in eGFR but do not modify long‐term kidney disease trajectories in chronic HF with reduced or preserved ejection fraction. Clinical Trial Registration: EMPHASIS‐HF (ClinicalTrials.gov NCT00232180) and TOPCAT (ClinicalTrials.gov NCT00094302).

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/ejhf.2635

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Cited by

See all 43

Metadata

Authors
Vaduganathan, M., Ferreira, J. P., Rossignol, P., Neuen, B. L., Claggett, B. L., Pfeffer, M. A., McMurray, J. J. V., Pitt, B., Zannad, F., & Solomon, S. D.
Venue
European Journal of Heart Failure
Published
2022-08-31
Volume
24
Issue
9
Pages
1586-1590
ISSN
  • 1388-9842 (ISSN-L)
  • 1879-0844
OpenAlex
W4286587591
Cited by
43
References
4
FWCI
5.18
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Effects of steroidal mineralocorticoid receptor antagonists on acute and chronic estimated glomerular filtration rate slopes in patients with chronic heart failure. https://app.cochat.ai/papers/10.1002/ejhf.2635
The paper
Vaduganathan, M., Ferreira, J. P., Rossignol, P., Neuen, B. L., Claggett, B. L., Pfeffer, M. A., McMurray, J. J. V., Pitt, B., Zannad, F., & Solomon, S. D. (2022). Effects of steroidal mineralocorticoid receptor antagonists on acute and chronic estimated glomerular filtration rate slopes in patients with chronic heart failure. European Journal of Heart Failure. https://doi.org/10.1002/ejhf.2635

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.